Insider Transactions in Q1 2022 at Medifast Inc (MED)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
953
+0.87%
|
-
|
|
Mar 21
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
953
-5.64%
|
-
|
|
Mar 17
2022
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-4.15%
|
$158,040
$180.52 P/Share
|
|
Mar 17
2022
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-2.39%
|
$13,500
$180.52 P/Share
|
|
Mar 16
2022
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,509
+28.7%
|
-
|
|
Mar 16
2022
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
548
+45.48%
|
-
|
|
Mar 16
2022
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,281
+29.01%
|
-
|
|
Mar 10
2022
|
Andrea B Thomas Director |
SELL
Open market or private sale
|
Direct |
1,150
-41.22%
|
$200,100
$174.31 P/Share
|
|
Feb 23
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
3,375
+3.05%
|
-
|
|
Feb 23
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
3,375
-16.66%
|
-
|
|
Feb 22
2022
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-10.35%
|
$546,222
$177.06 P/Share
|
|
Feb 04
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
266
+0.75%
|
$49,476
$186.4 P/Share
|
|
Feb 04
2022
|
Daniel R Chard Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
690
+0.66%
|
$128,340
$186.4 P/Share
|
|
Jan 03
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
12,539
+10.84%
|
-
|
|
Jan 03
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
12,539
-44.38%
|
-
|